vs
AdvanSix Inc.（ASIX）与Waystar Holding Corp.（WAY）财务数据对比。点击上方公司名可切换其他公司
AdvanSix Inc.的季度营收约是Waystar Holding Corp.的1.1倍（$359.9M vs $313.9M），Waystar Holding Corp.净利率更高（13.8% vs -0.8%，领先14.6%），Waystar Holding Corp.同比增速更快（22.4% vs 9.4%），Waystar Holding Corp.自由现金流更多（$90.3M vs $36.1M），过去两年Waystar Holding Corp.的营收复合增速更高（15.7% vs 3.4%）
AdvanSix Inc.是一家美国化工企业，主营尼龙6以及己内酰胺、硫酸铵肥料等相关化工产品。该公司原为霍尼韦尔旗下树脂与化工事业部，于2016年分拆独立，2019年预估营收达14亿美元，其企业历史可追溯至1884年在宾夕法尼亚州法兰克福成立的H. W. Jayne公司。
Waystar Holding Corp是一家领先的医疗健康支付与营收周期管理解决方案提供商，服务覆盖美国各地的医疗机构、医疗系统和支付方，旗下工具可简化账单处理、理赔申请、患者缴费流程，帮助医疗机构降低行政负担、优化营收表现。
ASIX vs WAY — 直观对比
营收规模更大
ASIX
是对方的1.1倍
$313.9M
营收增速更快
WAY
高出13.0%
9.4%
净利率更高
WAY
高出14.6%
-0.8%
自由现金流更多
WAY
多$54.1M
$36.1M
两年增速更快
WAY
近两年复合增速
3.4%
损益表 — Q4 FY2025 vs Q1 FY2026
| 指标 | | |
|---|---|---|
| 营收 | $359.9M | $313.9M |
| 净利润 | $-2.8M | $43.3M |
| 毛利率 | 7.6% | — |
| 营业利润率 | -0.7% | 25.6% |
| 净利率 | -0.8% | 13.8% |
| 营收同比 | 9.4% | 22.4% |
| 净利润同比 | -892.9% | 47.9% |
| 每股收益（稀释后） | $-0.11 | $0.42 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收ASIXWAY
| Q1 26 | — | $313.9M | ||
| Q4 25 | $359.9M | $303.5M | ||
| Q3 25 | $374.5M | $268.7M | ||
| Q2 25 | $410.0M | $270.7M | ||
| Q1 25 | $377.8M | $256.4M | ||
| Q4 24 | $329.1M | $244.1M | ||
| Q3 24 | $398.2M | $240.1M | ||
| Q2 24 | $453.5M | $234.5M |
净利润ASIXWAY
| Q1 26 | — | $43.3M | ||
| Q4 25 | $-2.8M | $20.0M | ||
| Q3 25 | $-2.6M | $30.6M | ||
| Q2 25 | $31.4M | $32.2M | ||
| Q1 25 | $23.3M | $29.3M | ||
| Q4 24 | $352.0K | $19.1M | ||
| Q3 24 | $22.3M | $5.4M | ||
| Q2 24 | $38.9M | $-27.7M |
毛利率ASIXWAY
| Q1 26 | — | — | ||
| Q4 25 | 7.6% | — | ||
| Q3 25 | 6.8% | — | ||
| Q2 25 | 14.3% | — | ||
| Q1 25 | 14.2% | — | ||
| Q4 24 | 3.4% | — | ||
| Q3 24 | 14.4% | — | ||
| Q2 24 | 17.9% | — |
营业利润率ASIXWAY
| Q1 26 | — | 25.6% | ||
| Q4 25 | -0.7% | 19.4% | ||
| Q3 25 | -0.9% | 22.4% | ||
| Q2 25 | 7.7% | 24.0% | ||
| Q1 25 | 7.7% | 25.4% | ||
| Q4 24 | -3.9% | 21.8% | ||
| Q3 24 | 7.5% | 11.3% | ||
| Q2 24 | 11.5% | 3.5% |
净利率ASIXWAY
| Q1 26 | — | 13.8% | ||
| Q4 25 | -0.8% | 6.6% | ||
| Q3 25 | -0.7% | 11.4% | ||
| Q2 25 | 7.7% | 11.9% | ||
| Q1 25 | 6.2% | 11.4% | ||
| Q4 24 | 0.1% | 7.8% | ||
| Q3 24 | 5.6% | 2.3% | ||
| Q2 24 | 8.6% | -11.8% |
每股收益（稀释后）ASIXWAY
| Q1 26 | — | $0.42 | ||
| Q4 25 | $-0.11 | $0.10 | ||
| Q3 25 | $-0.10 | $0.17 | ||
| Q2 25 | $1.15 | $0.18 | ||
| Q1 25 | $0.86 | $0.16 | ||
| Q4 24 | $0.02 | $0.18 | ||
| Q3 24 | $0.82 | $0.03 | ||
| Q2 24 | $1.43 | $-0.21 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $19.8M | $34.3M |
| 总债务越低越好 | — | $13.5M |
| 股东权益账面价值 | $815.2M | $3.9B |
| 总资产 | $1.7B | $5.8B |
| 负债/权益比越低杠杆越低 | — | 0.00× |
8季度趋势，按日历期对齐
现金及短期投资ASIXWAY
| Q1 26 | — | $34.3M | ||
| Q4 25 | $19.8M | $61.4M | ||
| Q3 25 | $23.7M | $421.1M | ||
| Q2 25 | $18.4M | $290.3M | ||
| Q1 25 | $8.3M | $224.0M | ||
| Q4 24 | $19.6M | $182.1M | ||
| Q3 24 | $17.3M | $127.1M | ||
| Q2 24 | $12.1M | $68.4M |
总债务ASIXWAY
| Q1 26 | — | $13.5M | ||
| Q4 25 | — | $1.5B | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | $1.2B | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — |
股东权益ASIXWAY
| Q1 26 | — | $3.9B | ||
| Q4 25 | $815.2M | $3.9B | ||
| Q3 25 | $818.2M | $3.2B | ||
| Q2 25 | $823.7M | $3.2B | ||
| Q1 25 | $794.4M | $3.1B | ||
| Q4 24 | $774.6M | $3.1B | ||
| Q3 24 | $766.4M | $3.1B | ||
| Q2 24 | $746.6M | $2.9B |
总资产ASIXWAY
| Q1 26 | — | $5.8B | ||
| Q4 25 | $1.7B | $5.8B | ||
| Q3 25 | $1.7B | $4.7B | ||
| Q2 25 | $1.6B | $4.7B | ||
| Q1 25 | $1.6B | $4.6B | ||
| Q4 24 | $1.6B | $4.6B | ||
| Q3 24 | $1.5B | $4.5B | ||
| Q2 24 | $1.5B | $4.6B |
负债/权益比ASIXWAY
| Q1 26 | — | 0.00× | ||
| Q4 25 | — | 0.38× | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | 0.40× | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $63.7M | $84.9M |
| 自由现金流经营现金流 - 资本支出 | $36.1M | $90.3M |
| 自由现金流率自由现金流/营收 | 10.0% | 28.8% |
| 资本支出强度资本支出/营收 | 7.7% | — |
| 现金转化率经营现金流/净利润 | — | 1.96× |
| 过去12个月自由现金流最近4个季度 | $6.4M | $314.6M |
8季度趋势，按日历期对齐
经营现金流ASIXWAY
| Q1 26 | — | $84.9M | ||
| Q4 25 | $63.7M | $66.6M | ||
| Q3 25 | $26.6M | $82.0M | ||
| Q2 25 | $21.1M | $96.8M | ||
| Q1 25 | $11.4M | $64.2M | ||
| Q4 24 | $64.2M | — | ||
| Q3 24 | $57.3M | $78.8M | ||
| Q2 24 | $50.2M | $15.4M |
自由现金流ASIXWAY
| Q1 26 | — | $90.3M | ||
| Q4 25 | $36.1M | $57.2M | ||
| Q3 25 | $66.0K | $76.2M | ||
| Q2 25 | $-7.2M | $91.0M | ||
| Q1 25 | $-22.6M | $58.8M | ||
| Q4 24 | $29.8M | — | ||
| Q3 24 | $26.8M | $70.2M | ||
| Q2 24 | $16.7M | $8.6M |
自由现金流率ASIXWAY
| Q1 26 | — | 28.8% | ||
| Q4 25 | 10.0% | 18.9% | ||
| Q3 25 | 0.0% | 28.3% | ||
| Q2 25 | -1.7% | 33.6% | ||
| Q1 25 | -6.0% | 22.9% | ||
| Q4 24 | 9.1% | — | ||
| Q3 24 | 6.7% | 29.2% | ||
| Q2 24 | 3.7% | 3.7% |
资本支出强度ASIXWAY
| Q1 26 | — | — | ||
| Q4 25 | 7.7% | 3.1% | ||
| Q3 25 | 7.1% | 2.2% | ||
| Q2 25 | 6.9% | 2.1% | ||
| Q1 25 | 9.0% | 2.1% | ||
| Q4 24 | 10.4% | — | ||
| Q3 24 | 7.7% | 3.6% | ||
| Q2 24 | 7.4% | 2.9% |
现金转化率ASIXWAY
| Q1 26 | — | 1.96× | ||
| Q4 25 | — | 3.33× | ||
| Q3 25 | — | 2.68× | ||
| Q2 25 | 0.67× | 3.01× | ||
| Q1 25 | 0.49× | 2.20× | ||
| Q4 24 | 182.29× | — | ||
| Q3 24 | 2.57× | 14.56× | ||
| Q2 24 | 1.29× | — |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
ASIX
| Plant Nutrients | $140.0M | 39% |
| Chemical Intermediates | $92.8M | 26% |
| Caprolactam | $64.4M | 18% |
| Nylon Resins | $62.8M | 17% |
WAY
| Subscription | $172.2M | 55% |
| Volume-based | $139.5M | 44% |
